BDBM696077 N2-[[1-(difluoromethyl)pyrazol-3-yl]methyl]-6-(1H-indazol-6-yl)-1,3,5-triazine-2,4-diamine::US20240300936, Example 68::US20240300936, Example 81

SMILES Nc1nc(NCc2ccn(n2)C(F)F)nc(n1)-c1ccc2cn[nH]c2c1

InChI Key InChIKey=DWFNTNUXEBOJMX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 696077   

TargetSerine/threonine-protein kinase greatwall(Human)
Avelos Therapeutics

US Patent
LigandPNGBDBM696077(US20240300936, Example 68 | US20240300936, Example...)
Affinity DataIC50: 2.95nMAssay Description:Wild-type human MASTL (0.5 nM) was incubated in assay buffer (30 mM HEPES, 100 mM NaCl, 0.5 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, 0.5 mM TCEP, pH 7.5...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/8/2025
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase greatwall(Human)
Avelos Therapeutics

US Patent
LigandPNGBDBM696077(US20240300936, Example 68 | US20240300936, Example...)
Affinity DataIC50: 1.05nMAssay Description:Wild-type human MASTL (0.5 nM) was incubated in assay buffer (30 mM HEPES, 100 mM NaCl, 0.5 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, 0.5 mM TCEP, pH 7.5...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/8/2025
Entry Details
Go to US Patent